UN Negotiating Price of Takeda’s New Dengue Vaccine

The World Health Organization’s (WHO’s) Pan American Health Organization (PAHO) is working with Takeda to negotiate pricing for the manufacturer’s new dengue vaccine Qdenga, the only one for the widespread illness. A key strategy being proposed is that large nations can pool their resources to purchase the vaccines in bulk at a lower price.

According to Zoey Becker, “PAHO is an international health agency that works with its 35 member states to set health priorities, respond to emergencies and strengthen health systems, especially in response to communicable and non-communicable diseases that cross borders. It also serves as the World Health Organization’s regional office of the Americas.”

To read more, click here.

(Source: Fierce Pharma, April 21^st, 2023)